Daily Archive: March 30, 2020

Dyadic Announces Nonexclusive Research License with WuXi Biologics

JUPITER, FL / ACCESSWIRE / March 30, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products, at flexible commercial scales, […]

Dyadic Announces Nonexclusive Research License with WuXi Biologics

JUPITER, FL / ACCESSWIRE / March 30, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products, at flexible commercial scales, […]